{"created":"2024-10-25T09:57:25.494681+00:00","id":2003168,"links":{},"metadata":{"_buckets":{"deposit":"3628431b-be35-42ae-9721-eef039d72d5e"},"_deposit":{"created_by":7,"id":"2003168","owners":[7],"pid":{"revision_id":0,"type":"depid","value":"2003168"},"status":"published"},"_oai":{"id":"oai:tokushima-u.repo.nii.ac.jp:02003168","sets":["1713829974766:1713854682253:1716422249595:1716422933660","1713853213384:1713853295607"]},"author_link":["798","209","1563","1542"],"item_10001_alternative_title_1":{"attribute_name":"タイトル別表記","attribute_value_mlt":[{"subitem_alternative_title":"A case of anaplastic lymphoma kinase-positive non-small cell lung cancer with a poor performance status successfully treated with crizotinib","subitem_alternative_title_language":"en"}]},"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-12-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"5-6","bibliographicPageEnd":"148","bibliographicPageStart":"141","bibliographicVolumeNumber":"71","bibliographic_titles":[{"bibliographic_title":"四国医学雑誌","bibliographic_titleLang":"ja"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"A ２７-year-old female was referred to our hospital for further examination of hoarseness, cough, and hemoptysis. Positron emission tomography-computed tomography revealed FDG accumulation in a huge mass in the left lower lobe, lymph nodes in the hilum, mediastinum and right cervical lesion left scapula and vertebral body. Further examination yielded the diagnosis of primary lung adenocarcinoma （cT２aN３M１b : Stage IV） harboring the anaplastic lymphoma kinase （ALK） fusion oncogene. Although her general condition was getting worse due to rapid increase of the pleural effusion, crizotinib promptly diminish the pleural effusion and ameliorated the patient’s condition. The adverse events of crizotinib, such as nausea, vomiting and visual disturbance, were generally mild and well tolerable during treatment. These findings suggest that crizotinib is a promising candidate for ALK-positive non-small cell lung cancer patients even with poor performances.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"徳島医学会","subitem_publisher_language":"ja"}]},"item_10001_source_id_9":{"attribute_name":"収録物ID","attribute_value_mlt":[{"subitem_source_identifier":"00373699","subitem_source_identifier_type":"ISSN"},{"subitem_source_identifier":"AN00102041","subitem_source_identifier_type":"NCID"}]},"item_10001_version_type_20":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1715043197608":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access"}]},"item_1723180141928":{"attribute_name":"EID","attribute_value_mlt":[{"subitem_identifier_type":"URI","subitem_identifier_uri":"306784"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"梶田, 敬介","creatorNameLang":"ja"},{"creatorName":"カジタ, ケイスケ","creatorNameLang":"ja-Kana"},{"creatorName":"Kajita, Keisuke","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"佐藤, 正大","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"798","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"豊田, 優子","creatorNameLang":"ja"},{"creatorName":"トヨダ, ユウコ","creatorNameLang":"ja-Kana"},{"creatorName":"Toyoda, Yuko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"坂口, 暁","creatorNameLang":"ja"},{"creatorName":"サカグチ, サトシ","creatorNameLang":"ja-Kana"},{"creatorName":"Sakaguchi, Satoshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"手塚, 敏史","creatorNameLang":"ja"},{"creatorName":"テズカ, トシフミ","creatorNameLang":"ja-Kana"},{"creatorName":"Tezuka, Toshifumi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"後東, 久嗣","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"209","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"埴淵, 昌毅","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"1563","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"西岡, 安彦","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"1542","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2016-10-21"}],"displaytype":"detail","filename":"LID201610212005.pdf","filesize":[{"value":"2.07 MB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://tokushima-u.repo.nii.ac.jp/record/2003168/files/LID201610212005.pdf"},"version_id":"be1c3061-c97a-40d5-b8b7-7a9a995f2cee"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"crizotinib","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"anaplastic lymphoma kinase","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"non-small cell lung cancer","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"performance status","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"クリゾチニブが奏効した Performance Status 不良 anaplastic lymphoma kinase 遺伝子転座陽性肺腺癌の1例","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"クリゾチニブが奏効した Performance Status 不良 anaplastic lymphoma kinase 遺伝子転座陽性肺腺癌の1例","subitem_title_language":"ja"},{"subitem_title":"クリゾチニブ ガ ソウコウ シタ Performance Status フリョウ anaplastic lymphoma kinase イデンシ テンザ ヨウセイ ハイセンガン ノ 1レイ","subitem_title_language":"ja-Kana"}]},"item_type_id":"40001","owner":"7","path":["1713853295607","1716422933660"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2016-10-21"},"publish_date":"2016-10-21","publish_status":"0","recid":"2003168","relation_version_is_last":true,"title":["クリゾチニブが奏効した Performance Status 不良 anaplastic lymphoma kinase 遺伝子転座陽性肺腺癌の1例"],"weko_creator_id":"7","weko_shared_id":-1},"updated":"2024-10-28T01:35:26.932410+00:00"}